FROVA (frovatriptan succinate) tablets contain frovatriptan succinate, a selective 5-hydroxy-tryptamine1 (5-HT1B/1D) receptor subtype agonist, as the active ingredient. Frovatriptan succinate is chemically designated as R-(+) 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole monosuccinate monohydrate and it has the following structure:
FROVA (frovatriptan succinate) structural formula illustration
The empirical formula is C14H17N3O.C4H6O4.H2O, representing a molecular weight of 379.4. Frovatriptan succinate is a white to off-white powder that is soluble in water. Each FROVA tablet for oral administration contains 3.91 mg frovatriptan succinate, equivalent to 2.5 mg of frovatriptan base. Each tablet also contains the inactive ingredients lactose NF, microcrystalline cellulose NF, colloidal silicon dioxide NF, sodium starch glycolate NF, magnesium stearate NF, hydroxypropylmethylcellulose USP, polyethylene glycol 3000 USP, triacetin USP, and titanium dioxide USP.
Perhaps does not have aspirin, ibuprofen or any NSAID
- Frova Information for Consumers
- Frova Information for Healthcare Professionals (includes dosage details)
- Side Effects of Frova (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 29 Jan 2010 • 1 answer
Posted 20 Mar 2013 • 1 answer
Posted 5 May 2013 • 2 answers
Posted 16 Apr 2016 • 2 answers
Posted 14 Aug 2016 • 0 answers